Association Between Histone Methyltransferase hSETD1A and Prognosis in Patients With Triple-Negative Breast Cancer After Surgery: A Retrospective Study in the Chinese Female Population
- PMID: 27227949
- PMCID: PMC4902373
- DOI: 10.1097/MD.0000000000003783
Association Between Histone Methyltransferase hSETD1A and Prognosis in Patients With Triple-Negative Breast Cancer After Surgery: A Retrospective Study in the Chinese Female Population
Abstract
Breast cancer, the most common cancer in women, is a serious public health issue. Triple-negative breast cancer (TNBC), which lacks expression of the estrogen receptor (ER), progesterone receptor, and human epidermal growth factor receptor 2, accounts for ∼15% of breast cancer cases. Treatment of TNBC patients has proven difficult because of the lack of expression of hormone receptors. We conducted a retrospective study to investigate the prognostic impact of histone methyltransferase, hSETD1A, on overall survival in TNBC cases after surgery. In total, 159 TNBC cases were enrolled and clinicopathological characteristics were obtained from medical records. hSETD1A status of each subject was determined using immunohistochemistry. The chi-squared test was used to compare 5-year overall survival rates of all subjects according to clinical characteristics, and both univariate and multivariate analyses were conducted to calculate the hazard ratios and 95% confidence intervals. Advanced tumor-node-metastasis stage stage, larger tumor size, vascular invasion, metastasis in the initial diagnosis, and hSETD1A expression were correlated with worse outcome. Among all factors identified, metastasis in the initial diagnosis had the greatest impact on survival. The results indicated that hSETD1A positivity was correlated with shorter survival among TNBC cases, suggesting it may serve as a prognostic biomarker for patients with TNBC.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures



Similar articles
-
Clinicopathological and prognostic characteristics of triple- negative breast cancer (TNBC) in Chinese patients: a retrospective study.Asian Pac J Cancer Prev. 2013;14(6):3779-84. doi: 10.7314/apjcp.2013.14.6.3779. Asian Pac J Cancer Prev. 2013. PMID: 23886182
-
Clinicopathological characteristics of triple negative breast cancer at a tertiary care hospital in India.Asian Pac J Cancer Prev. 2014;15(24):10577-83. doi: 10.7314/apjcp.2014.15.24.10577. Asian Pac J Cancer Prev. 2014. PMID: 25605142
-
Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt.Exp Mol Pathol. 2015 Oct;99(2):303-11. doi: 10.1016/j.yexmp.2015.07.014. Epub 2015 Jul 30. Exp Mol Pathol. 2015. PMID: 26232605
-
An overview of triple-negative breast cancer.Arch Gynecol Obstet. 2016 Feb;293(2):247-69. doi: 10.1007/s00404-015-3859-y. Epub 2015 Sep 4. Arch Gynecol Obstet. 2016. PMID: 26341644 Review.
-
Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.Clin Breast Cancer. 2017 Aug;17(5):382-391. doi: 10.1016/j.clbc.2017.04.009. Epub 2017 Apr 26. Clin Breast Cancer. 2017. PMID: 28529029 Free PMC article. Review.
Cited by
-
Clinicopathologic significance of protein lysine methyltransferases in cancer.Clin Epigenetics. 2020 Oct 13;12(1):146. doi: 10.1186/s13148-020-00897-3. Clin Epigenetics. 2020. PMID: 33050946 Free PMC article. Review.
-
The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge.J Breast Cancer. 2018 Sep;21(3):233-243. doi: 10.4048/jbc.2018.21.e41. Epub 2018 Sep 20. J Breast Cancer. 2018. PMID: 30275851 Free PMC article. Review.
-
Identification of a novel target of SETD1A histone methyltransferase and the clinical significance in pancreatic cancer.Cancer Sci. 2023 Feb;114(2):463-476. doi: 10.1111/cas.15615. Epub 2022 Nov 8. Cancer Sci. 2023. PMID: 36271761 Free PMC article.
References
-
- Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65:87–108. - PubMed
-
- Colditz GA, Sellers TA, Trapido E. Epidemiology—identifying the causes and preventability of cancer? Nat Rev Cancer 2006; 6:75–83. - PubMed
-
- Youlden DR, Cramb SM, Dunn NA, et al. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol 2012; 36:237–248. - PubMed
-
- Jemal A, Center MM, DeSantis C, et al. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 2010; 19:1893–1907. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials